Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Deep Brain Stimulation in Parkinson's Disease: Still Effective After More Than 8 Years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Improvement of oral function and hygiene in Parkinson's disease: A randomised controlled clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hereditære ataksier og sygdomme i det motoriske neuron

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiUndervisning

  5. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Anne-Lene Kjældgaard
  • Katrine Pilely
  • Karsten Skovgaard Olsen
  • Anders Hedegaard Jessen
  • Anne Øberg Lauritsen
  • Stephen Wørlich Pedersen
  • Kirsten Svenstrup
  • Merete Karlsborg
  • Helle Thagesen
  • Morten Blaabjerg
  • Ásta Theódórsdóttir
  • Elisabeth Gundtoft Elmo
  • Anette Torvin Møller
  • Lone Bonefeld
  • Mia Berg
  • Peter Garred
  • Kirsten Møller
Vis graf over relationer

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease with great heterogeneity. Biological prognostic markers are needed for the patients to plan future supportive treatment, palliative treatment, and end-of-life decisions. In addition, prognostic markers are greatly needed for the randomization in clinical trials.

OBJECTIVE: This study aimed to test the ALS Functional Rating Scale-Revised (ALSFRS-R) progression rate (ΔFS) as a prognostic marker of survival in a Danish ALS cohort.

METHODS: The ALSFRS-R score at test date in association with duration of symptoms, from the onset of symptoms until test date, (defined as ΔFS') was calculated for 90 Danish patients diagnosed with either probable or definite sporadic ALS. Median survival time was then estimated from the onset of symptoms until primary endpoint (either death or tracheostomy). ΔFS' was subjected to survival analysis using Cox proportional hazards modelling, log-rank test, and Kaplan-Meier survival analysis.

RESULTS AND CONCLUSIONS: Both ΔFS' and age was found to be strong predictors of survival of the Danish ALS cohort. Both variables are easily obtained at the time of diagnosis and could be used by clinicians and ALS patients to plan future supportive and palliative treatment. Furthermore, ΔFS', is a simple, prognostic marker that predicts survival in the early phase of disease as well as at later stages of the disease.

OriginalsprogEngelsk
Artikelnummer164
TidsskriftBMC Neurology
Vol/bind21
Udgave nummer1
Sider (fra-til)164
ISSN1471-2377
DOI
StatusUdgivet - dec. 2021

ID: 66256963